Histogen (NASDAQ:HSTO) Stock Price Down 70%

Shares of Histogen Inc. (NASDAQ:HSTO) traded down 70% during mid-day trading on Friday . The stock traded as low as $0.05 and last traded at $0.15. 955 shares were traded during mid-day trading, a decline of 96% from the average session volume of 21,550 shares. The stock had previously closed at $0.50.

Histogen Stock Down 70.0 %

The firm has a market capitalization of $640,927.00, a P/E ratio of -0.05 and a beta of 0.92. The firm has a 50 day moving average of $0.38 and a 200-day moving average of $0.38.

Institutional Investors Weigh In On Histogen

An institutional investor recently raised its position in Histogen stock. Renaissance Technologies LLC lifted its stake in Histogen Inc. (NASDAQ:HSTO) by 78.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,167,067 shares of the company’s stock after buying an additional 514,387 shares during the period. Renaissance Technologies LLC owned approximately 2.34% of Histogen worth $292,000 as of its most recent filing with the Securities and Exchange Commission.

Histogen Company Profile

Histogen Inc, a clinical-stage therapeutics company, focuses on developing clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body's natural process to restore immune function. The company's product candidates include emricasan for the treatment of acute bacterial skin and skin structure infections, as well as other infectious diseases.